Lisa Pham is a reporter for Bloomberg News, Fortune, Irish Examiner, and BNN Bloomberg. Her work has also been featured in publications such as Bloomberg Law, Moneyweb, Financial Post, The Japan Times, Yahoo Finance, and The Washington Post. Lisa covers a wide range of topics including finance, retail, healthcare, and environmental issues.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Lisa Pham's coverage primarily focuses on health and finance, with an emphasis on investment analysis and citing data. To effectively reach out to her, consider offering insights or expert commentary related to the intersection of health and finance such as the impact of healthcare trends on stock markets, emerging opportunities in the pharmaceutical industry, or analyses regarding the financial implications of health-related regulatory changes.
Given that Lisa covers ESG campaigns falling out of favor with activist investors among other topics like obesity drugs and retail, she may be interested in receiving pitches from experts who can provide unique perspectives on evolving consumer trends in these areas. If you have proprietary data or specialized knowledge about how these factors are impacting industries from a financial perspective, it could make for a compelling pitch to Lisa.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Macarena Muñoz, Lisa Pham
Grifols' Worst-Ever Year Can't Derail Analyst Calls to Buy Lisa Pham and Macarena Muñoz 3 min read In This Article
Das Global Wealth Management der UBS hält es für unwahrscheinlich, dass die Rückkehr von Donald Trump ins Weiße Haus die Argumente für Investments untergräbt, bei denen Umweltaspekte, soziale Verantwortung und gute Unternehmensführung im Fokus stehen.
By: Sonja Wind, Lisa Pham
For Hugo Boss AG investors, 2024 is a year to forget.
German firm's stock is on track for biggest drop since 2008 UK retail tycoon Ashley's Frasers may look for a board seat
By: Sonja Wind, Lisa Pham
Para los inversionistas de Hugo Boss AG, 2024 será un año para el olvido.
After falling off their perch in the last few months of 2024, European healthcare stocks head into a new year facing the jeopardy of US politics and high-stakes trial results for new drugs.
In This Article NSRGF (Bloomberg) -- Nestle SA's slumping stock valuation has made it irresistible for money manager J.
Hi, it’s Lisa in London, where I recently discovered how cortisol levels can affect a person’s ability to function in the morning — which is particularly important for people suffering from long Covid. But before we get to that...
By: Angel Adegbesan, Lisa Pham
In This Article LLY ZEAL.CO VKTX AMGN NVO
By: Angel Adegbesan, Lisa Pham
Die Aktien der Hersteller für Medikamente gegen Fettleibigkeit fuhren 2024 Achterbahn. Die enttäuschenden Studienergebnisse für das experimentelle Adipositas-Mittel CagriSema von Novo Nordisk beenden nun das volatile Jahr.
(833) 317-6278 
